INTRODUCTION
• Noonan Syndrome is a multiple malformation syndrome characterized by pulmonic stenosis and hypertrophic cardiomyopathy, ventricular or atrial septal defects, short stature, distinct craniofacial features, clotting factor deficiencies, and learning disabilities.
• Incidence is 1 in 1000-2500 births.
• Eight genes in the RAS/MAPK signaling pathway have been implicated in NS, the most common of which is PTPN11 (50%).
• Chronic pain is an uncommon feature of NS; there is little published information on this topic. 1 • After diagnosing a patient who presented with a chief complaint of chronic pain, we investigated the prevalence of this symptom in NS.
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• Categorical variables were analyzed using twosided Fisher's exact and Chi square tests.
• 45 questionnaires were submitted and analyzed.
• 53% of subjects were female.
• Mean age was 17.3 (2-48) years.
• 47% had a PTPN11 mutation, typical of the NS population.
• 62% (28/45) of subjects experienced chronic pain within the last three months (Figure 2 ).
• There was a significant relationship between presence of pain and residing in a cold climate (p=0.004; Figure 3 ).
• Pain occurred more commonly in extremities and joints than head and trunk (p=0.066; Table I ).
• Subjects with hyperextensible joints were more likely to have pain (p=0.052; Figure D ).
• The following had no significant relationship with presence of pain: prior surgery related to the site of pain (p=0.135), gender (p= 0.233), prevalence of any gene mutation (p=0.595).
• We found no significant relationship between GH therapy and "no chronic pain" (p=0.607).
RESULTS

CASE REPORT
• Our patient is an 11 year old girl referred to genetics clinic for evaluation of chronic, severe hand and foot pain since 2 years of age (Figure 1 ). Her family relocated to Arizona from the upper Midwest as her pain is significantly reduced in warmer weather.
CASE REPORT cont..'d
• Her PMH is positive for mitral valve prolapse, hyperopia, chronic abdominal pain due to food allergies, and intermittent dermatitis coinciding with episodes of pain.
• Her family history is negative for NS.
• On physical exam her height was 10-25th percentile. She was borderline macrocephalic with thick coarse hair; she had hypertelorism with posteriorly rotated ears, a rounded nasal tip, and full, lax cheeks. She had a slight pectus carinatum with widely spaced nipples, velvety skin with several café au lait spots and scattered erythematous circular lesions. Her joints showed FROM without swelling or erythema.
• Lactic acid, CPK, amino acids, carnitine profile, copper, ceruloplasmin, urine porphobilinogens, homocysteine, and DNA for Fabry disease were negative.
• Chromosomal microarray revealed a 370 kb dup on Xp22.33 and microdeletions of 378 kb on Xq28 and of 88 kb on 1p36.22. Her mother also carried both X chromosome variants.
• EMG/NCS and spine MRI were negative.
MRI of her feet revealed a focal signal abnormality in the left 4th metatarsal and a small left flexor hallucis longus tenosynovial effusion.
• IGF-1 was 89 ng/ml (133-416 ng/ml). She was started on human GH 0.3 mg/kg/day. In the first month of treatment she experienced a moderate improvement in her pain level.
• After two months her pain level improved dramatically, which has continued during her 18 months of therapy. On follow up evaluation she has had only mild exacerbations of pain, an overall significant improvement since living in the upper Midwest. 
